Active	Status	Sponsor type	Region	Phase	Filter
2 Active 1 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wu, Jianjun
NCT03977480: Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis	Terminated	2	70	RoW	Hemay007, Placebo	Tianjin Hemay Pharmaceutical Co., Ltd	Ulcerative Colitis	08/22	08/22
TQB2858-Ⅰ-06, NCT05068921: A Clinical Trial to Evaluate Tolerability and Pharmacokinetics of TQB2858 Injection in Subjects With Advanced Malignancy	Recruiting	1	40	RoW	TQB2858 injection	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Advanced Cervical Cancer	05/23	07/23